Mjt & Associates Financial Advisory Group, Inc. Neurocrine Biosciences Inc Transaction History
Mjt & Associates Financial Advisory Group, Inc.
- $123 Billion
- Q3 2025
A detailed history of Mjt & Associates Financial Advisory Group, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mjt & Associates Financial Advisory Group, Inc. holds 30 shares of NBIX stock, worth $4,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$4,571% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
697Shares Held
104MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$1.48 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$848 Million0.42% of portfolio
-
Jpmorgan Chase & CO New York, NY4.73MShares$721 Million0.04% of portfolio
-
State Street Corp Boston, MA4.47MShares$681 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...